New heart drug shows promise in early trial
Disease control
Completed
This study tested a new drug called AC01 in 58 adults with heart failure and reduced pumping ability. The goal was to check safety and how the body processes the drug. Participants received either AC01 or a placebo in increasing doses. The study is complete, but results are not y…
Phase: PHASE1, PHASE2 • Sponsor: AnaCardio AB • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC